Showing results (201-210 of 436) with videos related to
Sort By:
Pageof 44
British Journal of Haematology|August 31, 2006
Long-term outcome results of the first tandem autotransplant trial for multiple myelomaBart Barlogie, Guido J Tricot, Frits van Rhee, et al.Cell Division|October 20, 2006
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expressionAmel Dib, Timothy R Peterson, Laura Raducha-Grace, et al.British Journal of Haematology|April 25, 2009
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone diseaseAngela Pennisi, Xin Li, Wen Ling, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioningAshraf Badros, Bart Barlogie, Eric Siegel, et al.Blood|March 14, 2008
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaWei Xiong, Xiaosong Wu, Sarah Starnes, et al.Frontiers in Microbiology|June 28, 2019
Distinct Responses of the Nitrogen-Fixing Marine Cyanobacterium Trichodesmium to a Thermally Variable Environment as a Function of Phosphorus AvailabilityPingping Qu, Fei-Xue Fu, Joshua D Kling, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Randomized phase II designsLarry Rubinstein, John Crowley, Percy Ivy, et al.Child Maltreatment|September 24, 2021
Child Abuse Pediatricians Assess a Low Likelihood of Abuse in Half of 2890 Physical Abuse ConsultsKatie L Johnson, Emily C B Brown, Kenneth W Feldman, et al.Experimental Hematology|February 26, 2013
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activitySathisha Upparahalli Venkateshaiah, Sharmin Khan, Wen Ling, et al.Blood|April 20, 2002
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patientsJames R Berenson, John J Crowley, Thomas M Grogan, et al.Pageof 44